SCHEMBL261932

SCHEMBL261932

CCC(Nc1cn(C(CC)CC)c2cc(NC3CCCCC3)c(F)cc2c1=O)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.52
GAA P10253 2/20 0.52
KMT2A Q03164 2/20 0.52
FOXO1 Q12778 1/20 0.42
ALOX15 P16050 3/20 0.36
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
PDE10A Q9Y233 1/20 0.34
PIN1 Q13526 2/20 0.34
POLB P06746 2/20 0.33
LMNA P02545 2/20 0.33
CREBBP Q92793 1/20 0.33
HPGD P15428 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
S1PR3 Q99500 1/20 0.33
CASP3 P42574 1/20 0.32
KDM4E B2RXH2 1/20 0.32
TOP1 P11387 1/20 0.32
CNR1 P21554 1/20 0.32
CNR2 P34972 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4165411 0.86 MEN1 (0.52) MEN1GAAKMT2AFOXO1ALOX15
SCHEMBL265623 0.86 KMT2A (0.53) MEN1GAAKMT2AFOXO1ALOX15
SCHEMBL262164 0.86 MEN1 (0.52) MEN1GAAKMT2AFOXO1ALOX15
SCHEMBL266815 0.84 MEN1 (0.54) MEN1GAAKMT2AFOXO1ALOX15
SCHEMBL4180734 0.83 MEN1 (0.49) MEN1GAAKMT2AFOXO1ALOX15
Hydrochloric Acid SCHEMBL261650 0.83 MEN1 (0.52) MEN1GAAKMT2AFOXO1ALOX15
SCHEMBL4164354 0.82 MEN1 (0.46) MEN1GAAKMT2AFOXO1ALOX15
SCHEMBL4164344 0.82 MEN1 (0.46) MEN1GAAKMT2AFOXO1ALOX15
SCHEMBL4164348 0.82 MEN1 (0.46) MEN1GAAKMT2AFOXO1ALOX15
SCHEMBL261474 0.82 KMT2A (0.49) MEN1GAAKMT2AFOXO1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120136025-A1 QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF ASTELLAS PHARMA INC. (JP) 2012-05-31 US disclosed
US-8133882-B2 Quinolone derivative or pharmaceutically acceptable salt thereof ASTELLAS PHARMA INC (JP) 2012-03-13 US disclosed
EP-1995240-B1 QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF ASTELLAS PHARMA INC (JP) 2012-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120136025-A1 QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF P2RY10, P2RY12, P2RY11 MEN1 3327/4885GAA 4203/4885KMT2A 2966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.